Catheter Ablation for Ventricular Tachycardia After MI: A Reconstructed Individual Patient Data Meta-analysis of Randomised Controlled Trials
Authors:
- Rohin K ReddyRRRohin K Reddy
- James P HowardJHJames P Howard
- Yousif AhmadYAYousif Ahmad
- Matthew J Shun-ShinMSMatthew J Shun-Shin
- Florentina A SimaderFSFlorentina A Simader
- Alejandra A MiyazawaAMAlejandra A Miyazawa
- Keenan SalehKSKeenan Saleh
- Akriti NaraenANAkriti Naraen
- Jack W SamwaysJSJack W Samways
- George KatritsisGKGeorge Katritsis
- Jagdeep S MohalJMJagdeep S Mohal
- Nandita KazaNKNandita Kaza
Open Access
- 22 November 2023
- journal article
- research article
- Published by Radcliffe Medical Media Ltd in Arrhythmia and Electrophysiology Review
- Vol. 12, e26
Abstract
Background: The prognostic impact of ventricular tachycardia (VT) catheter ablation is an important outstanding research question. We undertook a reconstructed individual patient data meta-analysis of randomised controlled trials comparing ablation to medical therapy in patients developing VT after MI. Methods: We systematically identified all trials comparing catheter ablation to medical therapy in patients with VT and prior MI. The prespecified primary endpoint was reconstructed individual patient assessment of all-cause mortality. Prespecified secondary endpoints included trial-level assessment of all-cause mortality, VT recurrence or defibrillator shocks and all-cause hospitalisations. Prespecified subgroup analysis was performed for ablation approaches involving only substrate modification without VT activation mapping. Sensitivity analyses were performed depending on the proportion of patients with prior MI included. Results: Eight trials, recruiting a total of 874 patients, were included. Of these 874 patients, 430 were randomised to catheter ablation and 444 were randomised to medical therapy. Catheter ablation reduced all-cause mortality compared with medical therapy when synthesising individual patient data (HR 0.63; 95% CI [0.41–0.96]; p=0.03), but not in trial-level analysis (RR 0.91; 95% CI [0.67–1.23]; p=0.53; I2=0%). Catheter ablation significantly reduced VT recurrence, defibrillator shocks and hospitalisations compared with medical therapy. Sensitivity analyses were consistent with the primary analyses. Conclusion: In patients with postinfarct VT, catheter ablation reduces mortality.Keywords
This publication has 27 references indexed in Scilit:
- Ablation of Stable VTs Versus Substrate Ablation in Ischemic CardiomyopathyJACC, 2015
- Non-randomised comparison of acute and long-term outcomes of robotic versus manual ventricular tachycardia ablation in a single centre ischemic cohortJournal of Interventional Cardiac Electrophysiology, 2015
- Catheter Ablation for Ventricular Tachycardia in Patients with an Implantable Cardioverter Defibrillator (CALYPSO) Pilot TrialJournal of Cardiovascular Electrophysiology, 2014
- Reduction in Inappropriate Therapy and Mortality through ICD ProgrammingNew England Journal of Medicine, 2012
- Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curvesBMC Medical Research Methodology, 2012
- The Cochrane Collaboration's tool for assessing risk of bias in randomised trialsBMJ, 2011
- Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trialThe Lancet, 2010
- Prophylactic Catheter Ablation for the Prevention of Defibrillator TherapyNew England Journal of Medicine, 2007
- Quantifying heterogeneity in a meta‐analysisStatistics in Medicine, 2002
- Prognosis of patients with ventricular tachycardia and ventricular fibrillation: Role of the underlying etiologyJACC, 1988